CWPWF yields 11.16% · MRK yields 2.76%● Live data
📍 CWPWF pulled ahead of the other in Year 1
Combined, CWPWF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWPWF + MRK for your $10,000?
Concord New Energy Group Limited, an investment holding company, engages in the generation of power in the People's Republic of China and internationally. The company operates through Power Generation, Intelligent Operation and Maintenance, and Others segments. It is involved in the investment, engineering, procurement, construction, operation, and maintenance of wind and solar power plants; and provision of design, technical, and consultancy services. The company also engages in the sale of solar and new energy equipment; design, research, and exploitation of power systems; leasing of equipment; and investment and operation of solar and wind power plants. In addition, it provides finance lease services and energy internet services. The company sells its electric power to external power grid companies. As of December 31, 2021, it had 70 grid-connected wind and photovoltaic power plants with a total installed capacity of approximately 3,708 megawatts, which include 54 wind power plants with an installed capacity of 3,313 megawatts, as well as 16 photovoltaic power plants with an installed capacity of 394 megawatts. The company was formerly known as China Windpower Group Limited and changed its name to Concord New Energy Group Limited in March 2015. The company was founded in 2006 and is based in Admiralty, Hong Kong.
Full CWPWF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.